Search Results
10
Everything
Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904
March 19, 2025 08:30 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904
Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel
March 06, 2025 09:35 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel
Conduit Progresses Phase II of its AI Initiative with Sarborg
February 20, 2025 08:00 ET
|
Conduit Pharmaceuticals
Conduit Progresses Phase II of its AI Initiative with Sarborg
Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model
February 13, 2025 08:00 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model
Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note
February 11, 2025 09:00 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note
Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development
February 07, 2025 08:00 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development
Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence
January 28, 2025 05:30 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
January 23, 2025 08:00 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Inc. Announces Reverse Stock Split
Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune Pipeline
January 22, 2025 08:00 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune Pipeline
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics
December 12, 2024 07:30 ET
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics Approach